Global Glycated Hemoglobin Testing Market 2012-2016
- ID: 2703242
- November 2013
- Region: Global
- 51 Pages
The analysts forecast the Global Glycated Hemoglobin Testing market to grow at a CAGR of 10.10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of diabetes. The Global Glycated Hemoglobin Testing market has also been witnessing the growing use of point of care hemoglobin A1c testing. However, the presence of substitutes could pose a challenge to the growth of this market.
The report, the Global Glycated Hemoglobin Testing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Glycated Hemoglobin Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Abbott Laboratories, Alere Inc., Beckman Coulter Inc. and Roche Holdings AG.
Other vendors mentioned in the report are ARKRAY Inc., A. Menarini Diagnostics Ltd., Bayer AG, Bio-Rad Laboratories Inc., Diazyme Laboratories Inc., Pointe Scientific Inc., Randox Laboratories Ltd., Roche Holdings AG, Trinity Biotech plc, and Tosoh Corp.
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
The report is also available as part of our annual subscription offer. Please get in touch with our customer service team in order to find out more. SHOW LESS READ MORE >
01. Executive Summary
02. Scope of the Report
02.1 Market Overview
02.2 Product Offerings
03. Market Research Methodology
03.1 Market Research Process
03.2 Research Design
03.3 Research Methodology
04. List of Abbreviations
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Criteria
07.1 Global HbA1c POC Testing Market
07.2 Global HbA1c Laboratory Testing Market
08. Market Segmentation by Method
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2012
17.3 Other Prominent Vendors
17.3.1 Product Portfolio
18. Key Vendor Analysis
18.1 Abbott Laboratories
18.1.1 Business Overview
18.1.2 Business Segmentation
18.1.3 Key Information
18.1.4 SWOT Analysis
18.2 Alere Inc.
18.2.1 Business Overview
18.2.2 Business Segmentation
18.2.3 Key Information
18.2.4 SWOT Analysis
18.3 Beckman Coulter Inc.
18.3.1 Business Overview
18.3.2 Business Segmentation
18.3.3 Key Information
18.3.4 SWOT Analysis
18.4 Roche Holdings AG
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Glycated Hemoglobin Testing market 2012-2016 (US$ billion)
Exhibit 3: Global Glycated Hemoglobin Testing market Segmentation by Criteria
Exhibit 4: Global HbA1c POC Testing market 2012-2016 (US$ billion)
Exhibit 5: Global HbA1c Laboratory Testing Market 2012-2016 (US$ billion)
Exhibit 6: Global Glycated Hemoglobin Testing market 2012-2016 (in percentage)
Exhibit 7: Global Glycated Hemoglobin Testing market Segmentation by Method
Exhibit 8: Global Glycated Hemoglobin Testing market by Geographical Segmentation 2012
Exhibit 9: Business Segmentation of Abbott Laboratories
Exhibit 10: Business Segmentation of Alere Inc.
Exhibit 11: Business Segmentation of Beckman Coulter Inc.
Exhibit 12: Business Segmentation of Roche Holdings AG
Commenting on the report, an analyst from the team said: “POC HbA1c testing is an emerging trend in the Diagnostics Testing industry. The unavailability of spontaneous HbA1c test results is likely to affect the clinical decision making process, leading to delayed initiation of and adjustment to diabetes treatments. The failure to properly adjust treatments may cause patient incompliance and increase the risk of complications arising from the disease.
Physicians are currently embracing POC HbA1c testing methods, in order to improve patient care and ensure speedy availability of HbA1c results during a patient visit. In addition, POC tests provide patient comfort and standardized laboratory-quality results that are easy to use. Hence, the growing use of POC HbA1c testing is becoming a significant tool for physicians to monitor and effectively treat diabetic patients. ”
According to the report, one of the major drivers in the market is the increasing incidence of diabetes among the population, creating a need for HbA1c testing methods to diagnose and monitor diabetes.
Further, the report states that one of the key challenges confronting the market is the presence of substitutes such as glucose meters, test strips, lancets, and continuous blood glucose meters, which are used to monitor diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- A. Menarini Diagnostics Ltd.
- Abbott Laboratories
- Alere Inc.
- ARKRAY Inc.
- Bayer AG
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Diazyme Laboratories Inc.
- Pointe Scientific Inc.
- Randox Laboratories Ltd.
- Roche Holdings AG
- Roche Holdings AG.
- Tosoh Corp.
- Trinity Biotech plc